Lung Cancer Considered

Lung Cancer Considered

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca • Gilead • J&J • Summit

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(401)

IASLC LALCA Preview (in Spanish)

IASLC LALCA Preview (in Spanish)

Host Dr. Narjust Florez previews the 2024 Latin America Lung Cancer Meeting with co-chairs Dr. Lucia Viola, Dr. Andres Feliple Cardona and Dr. Stella Martinez. LALCA is a dynamic meeting with a long t...

24 Syys 202446min

ESMO 2024 Highlights

ESMO 2024 Highlights

This episode of Lung Cancer Considered covers the recently completed 2024 ESMO Congress in Barcelona. Host Dr. Stephen Liu discussed the important research presented at the meeting with Dr. Marina Gar...

20 Syys 202438min

FDA Approval: KEYNOTE 483, Pembrolizumab plus Chemotherapy for Mesothelioma

FDA Approval: KEYNOTE 483, Pembrolizumab plus Chemotherapy for Mesothelioma

In a special episode of Lung Cancer Considered, host Dr. Stephen Liu discuss the recent FDA approval of pembrolizumab plus platinum and pemetrexed for mesothelioma, based on the phase III KEYNOTE 483 ...

18 Syys 202422min

IASLC - ACLC 2024 Preview

IASLC - ACLC 2024 Preview

In this episode of Lung Cancer Consider, host Dr. Stephen Liu previews the upcoming IASLC 2024 Asia Conference on Lung Cancer with meeting co-chair, Dr. Feng-Ming (Spring) Kong.

18 Syys 202422min

FDA Approval: MARIPOSA2, Amivantamab plus Chemotherapy after Osimertinib for EGFR NSCLC

FDA Approval: MARIPOSA2, Amivantamab plus Chemotherapy after Osimertinib for EGFR NSCLC

Description: The FDA approved amivantamab therapy for EGFR mutant NSCLC after progression on osimertinib. This approval is based on the phase III MARIPOSA-2 trial, with data first shared at ESMO 202...

17 Syys 202423min

LCC in Portuguese: WCLC 2024 Highlights

LCC in Portuguese: WCLC 2024 Highlights

The 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversar...

12 Syys 202431min

Live From WCLC 2024: Nurse Practitioner Highlights

Live From WCLC 2024: Nurse Practitioner Highlights

In this special episode of Lung Cancer Considered, Stephanie McDonald and Jillian Thompson discuss their perspectives of attending the 2024 World Conference on Lung Cancer as nurse practitioners. Hea...

11 Syys 202413min

LCC in Spanish: WCLC 2024 Highlights

LCC in Spanish: WCLC 2024 Highlights

The 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversar...

11 Syys 202424min

Suosittua kategoriassa Tiede

rss-poliisin-mieli
tiedekulma-podcast
utelias-mieli
rss-mita-tulisi-tietaa
docemilia
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
rss-totuuden-liepeilla
rss-hereilla
rss-duokkari-ekstra
hippokrateen-vastaanotolla
sotataidon-ytimessa
rss-duodecim-lehti
rss-ylistys-elaimille
rss-kasvikutsut
filocast-filosofian-perusteet
rss-tiedetta-vai-tarinaa
rss-tervetta-skeptisyytta